- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Liver in New Zealand
Total 1712 results
-
Gilead SciencesCompleted
-
89bio, Inc.RecruitingMetabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With FibrosisUnited States
-
Gilead SciencesCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Canada
-
Galmed Research and Development, Ltd.Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS... and other collaboratorsCompletedLiver Diseases | Fatty Liver | Non-Alcoholic Steatohepatitis | Liver FibrosesUnited States, Chile, Israel, Italy, France, Germany, Mexico, Georgia, Lithuania, Hong Kong, Romania
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Axcella Health, IncRecruitingNon Alcoholic Steatohepatitis (NASH)United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Chinese University of Hong KongRecruitingPancreatic Cyst | Pancreatic SteatosisHong Kong
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Novartis PharmaceuticalsTerminated
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Japan, Sweden
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Gilead SciencesCompleted
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Rockefeller UniversityCornell UniversityCompletedObesity | Fatty Liver | Insulin ResistanceUnited States
-
Antipodean Pharmaceuticals, Inc.Completed
-
Arrowhead PharmaceuticalsCompleted
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Arrowhead PharmaceuticalsTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Assembly BiosciencesCompleted
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Gilead SciencesCompleted
-
Inventiva PharmaActive, not recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Netherlands, United Kingdom
-
State University of New York at BuffaloRecruitingFibrosis | Hepatitis B | Hepatitis C | Fatty Liver | Cirrhosis | Bariatric Surgery Candidate | Obesity, Childhood | Non-Alcoholic Steatohepatitis(NASH)United States
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Galectin Therapeutics Inc.Active, not recruitingCirrhosis | NASH - Nonalcoholic Steatohepatitis | Prevention of Esophageal VaricesUnited States, France, Spain, Australia, Canada, Israel, Puerto Rico, Belgium, Argentina, Chile, Germany, Korea, Republic of, Mexico, Poland, United Kingdom
-
AbbVieCompletedHepatic ImpairmentUnited States, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
HighTide Biopharma Pty LtdActive, not recruitingType 2 Diabetes | Nonalcoholic Steatohepatitis (NASH)United States, China, Hong Kong
-
Yale UniversityNational Institutes of Health (NIH)CompletedFatty Liver | Insulin ResistanceUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Arbor Research Collaborative for HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingEnd Stage Liver Disease | Mitochondrial Diseases | Acute Liver Failure | Respiratory Chain Deficiencies, Mitochondrial | Disorder of Fatty Acid OxidationUnited States, Canada
-
University of ZurichUniversity Hospital, Strasbourg, France; University College London Hospitals; University Hospital, Essen and other collaboratorsCompletedNeoplasmsUnited Kingdom, Germany, Switzerland, United States, France, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Zydus Lifesciences LimitedRecruitingObesity | Metabolic Syndrome | Dyslipidemias | Type 2 Diabetes | NAFLDIndia
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France